Papers and database versions

Paper titles open the publication. Database names open the source's documentation or release page. Exact input URLs, extraction scope and checksums remain in the downloadable provenance.

citation	paper	source_table	artifact
Gong et al. (2021)	The RNA landscape of the human placenta in health and disease	Supplementary Data 5: placenta rows	Extracted source
Gong et al. (2021)	The RNA landscape of the human placenta in health and disease	Supplementary Data 6: placenta rows	Extracted source
Bradley et al. (2020)	Vestigial-like 1 is a shared targetable cancer-placenta antigen expressed by pancreatic and basal-like breast cancers	Figure 3: ten CPA candidates	Extracted source
Wang et al. (2016)	Systematic identification of genes with a cancer-testis expression pattern in 19 cancer types	Supplementary Data 3A	Extracted source
Bruggeman et al. (2018)	Massive expression of germ cell-specific genes is a hallmark of cancer and a potential target for novel treatment development	1D	Extracted source
da Silva et al. (2017)	Genome-wide identification of cancer/testis genes and their association with prognosis in a pan-cancer analysis	1103 CTs predicted	Extracted source
da Silva et al. (2017)	Genome-wide identification of cancer/testis genes and their association with prognosis in a pan-cancer analysis	Sheet1	Extracted source
Jamin et al. (2021)	Combined RNA/tissue profiling identifies novel Cancer/testis genes	Expression data and classes	Extracted source
Jamin et al. (2021)	Combined RNA/tissue profiling identifies novel Cancer/testis genes	Annotation	Extracted source
Chang et al. (2019)	Comprehensive characterization of cancer-testis genes in testicular germ cell tumor	Suppl Table 2	Extracted source
Carter et al. (2023)	Identification of pan-cancer/testis genes and validation of therapeutic targeting in triple-negative breast cancer	Supplementary Table 2	Extracted source
Seager et al. (2024)	Cancer testis antigen burden (CTAB): a novel biomarker of tumor-associated antigens in lung cancer	Methods: Data processing and statistical analysis; Figure 1	Extracted source
Loriot et al. (2025)	A survey of human cancer-germline genes: Linking X chromosome localization, DNA methylation and sex-biased expression in early embryos	List of 146 CG genes	Extracted source
Loriot et al. (2025)	A survey of human cancer-germline genes: Linking X chromosome localization, DNA methylation and sex-biased expression in early embryos	List of 134 CG-Preferential gen	Extracted source
Gong et al. (2021)	The RNA landscape of the human placenta in health and disease	Data 5 - tissue-enriched PC	Extracted source
Gong et al. (2021)	The RNA landscape of the human placenta in health and disease	Data 6 tissue-enriched lncR	Extracted source
da Silva et al. (2017)	Genome-wide identification of cancer/testis genes and their association with prognosis in a pan-cancer analysis	Supplementary_Table3	Extracted source
Bai et al. (2016)	EGFL6 regulates the asymmetric division, maintenance and metastasis of ALDH+ ovarian cancer cells	Abstract	Extracted source
Boël et al. (1995)	BAGE: a new gene encoding an antigen recognized on human melanomas by cytolytic T lymphocytes.	Targeted primary nomination: BAGE; PMID 7895173	Extracted source
Garg et al. (2007)	Sperm-associated antigen 9, a novel cancer testis antigen, is a potential target for immunotherapy in epithelial ovarian cancer.	Targeted primary nomination: SPAG9; PMID 17332284	Extracted source
Sasaroli et al. (2011)	Novel surface targets and serum biomarkers from the ovarian cancer vasculature	Results: 13 promising genes; Figure 2B	Extracted source
Hirbo et al. (2015)	Integrating Diverse Types of Genomic Data to Identify Genes that Underlie Adverse Pregnancy Phenotypes	S1 Table: J4:J89; AC4:AF33 tracks the 30 fast-evolving subset	Extracted source

Measurement resources

name	evidence_category	native_unit	source_url
Reviewed human gene knowledge: normal cells and reproductive protein	normal_protein	source-native qualitative and quantitative observations	Source
Reviewed human gene knowledge: normal cells and reproductive protein	normal_cell_rna	source-native qualitative and quantitative observations	Source
Reviewed human gene knowledge: normal cells and reproductive protein	reproductive_expression	source-native qualitative and quantitative observations	Source
Durante et al. 2020 adult human olfactory atlas supplementary tables	normal_cell_rna	positive neurons; cluster detection fraction	Source
Verbeurgt et al. 2014 whole human olfactory mucosa	normal_cell_rna	native qPCR Cq; assay IDs and donor identity	Source
Verbeurgt et al. 2014 whole human olfactory mucosa	normal_cell_rna	estimated RNA copies per 20 ng total RNA	Source
Published human normal immune induction contexts	reproductive_expression	qualitative reported RNA induction	Source
Published human normal immune induction contexts	normal_cell_rna	qualitative reported RNA induction	Source
HPA v23 / GTEx consensus	normal_bulk_rna	nTPM	Source
HPA v23 / GTEx consensus	reproductive_expression	nTPM	Source
Tyser human gastrulation atlas	developmental_expression	TPM	Source
Petropoulos preimplantation atlas	developmental_expression	TPM	Source
HPA v23 human brain, 193 subregions	normal_bulk_rna	nTPM	Source
Direct GTEx v11 tissue medians	normal_bulk_rna	TPM	Source
OncoRef source-mapped tumor union	tumor_expression	TPM	Source
HPA v23 cancer sample measurements	tumor_expression	pTPM	Source
HPA v23 tissue/cell clusters	normal_cell_rna	nTPM	Source
HPA v23 tissue/cell clusters	reproductive_expression	nTPM	Source
HPA v23 immune summaries	immune_rna	nTPM	Source
Monaco immune summaries via HPA v23	immune_rna	TPM	Source
DICE immune distributions	immune_rna	TPM	Source
Collin adult corneal atlas	normal_cell_rna	CP10K	Source
HPA v23 normal-tissue IHC	normal_protein	HPA categorical level and reliability	Source
HPA v23 normal-tissue IHC	reproductive_expression	HPA categorical level and reliability	Source
Curated external staining observations	normal_protein	native categorical findings	Source
Reviewed normal protein and clinical exclusions	normal_protein	categorical reviewed findings	Source
Reviewed normal protein and clinical exclusions	clinical_safety	categorical reviewed findings	Source
Letetresgene Autoleucel in Advanced/Metastatic Myxoid/Round Cell Liposarcoma	clinical_safety	reviewed clinical attribution	Source
Autologous T cell therapy for PRAME+ advanced solid tumors in HLA-A*02+ patients: a phase 1 trial	clinical_safety	reviewed clinical attribution	Source
Autologous T cell therapy for MAGE-A4+ solid cancers in HLA-A*02+ patients: a phase 1 trial	clinical_safety	reviewed clinical attribution	Source
SPEARHEAD-1: a single-arm phase 2 trial of afamitresgene autoleucel in advanced synovial sarcoma and myxoid/round cell liposarcoma	clinical_safety	reviewed clinical attribution	Source
Identification of a Titin-Derived HLA-A1-Presented Peptide as a Cross-Reactive Target for Engineered MAGE A3-Directed T Cells	clinical_safety	reviewed clinical attribution	Source
Guillain-Barre syndrome observed with adoptive transfer of lymphocytes genetically engineered with an NY-ESO-1 reactive T-cell receptor	clinical_safety	reviewed clinical attribution	Source
NCT03709706 protocol: NY-ESO-1/LAGE-1A shared peptide and c259 receptor	clinical_safety	reviewed clinical attribution	Source
NCT03132922 protocol: MAGE-A4 c1032 target peptide	clinical_safety	reviewed clinical attribution	Source
First-in-human dose escalation trial to evaluate the clinical safety and efficacy of an anti-MAGEA1 autologous TCR-transgenic T cell therapy in relapsed and refractory solid tumors	clinical_safety	reviewed clinical attribution	Source
Phase I clinical trial evaluating the safety and efficacy of ADP-A2M10 SPEAR T cells in patients with MAGE-A10+ advanced non-small cell lung cancer	clinical_safety	reviewed clinical attribution	Source
NY-ESO-1-specific redirected T cells with endogenous TCR knockdown mediate tumor response and cytokine release syndrome	clinical_safety	reviewed clinical attribution	Source
Cancer regression and neurological toxicity following anti-MAGE-A3 TCR gene therapy	clinical_safety	reviewed clinical attribution	Source
Gong et al., Nature Communications (2021)	nomination	gene-list membership	Source
Gong et al., Nature Communications (2021)	nomination	gene-list membership	Source
Bradley et al., Nature Communications (2020)	nomination	gene-list membership	Source
Wang 2016	nomination	gene-list membership	Source
Bruggeman 2018	nomination	gene-list membership	Source
da Silva 2017 · testis-biased	nomination	gene-list membership	Source
da Silva 2017 · CT	nomination	gene-list membership	Source
Jamin 2021	nomination	gene-list membership	Source
Jamin 2021 · core	nomination	gene-list membership	Source
Chang 2019 · TGCT	nomination	gene-list membership	Source
Carter 2023	nomination	gene-list membership	Source
Seager 2024 · panel	nomination	gene-list membership	Source
Loriot 2025 · strict	nomination	gene-list membership	Source
Loriot 2025 · preferential	nomination	gene-list membership	Source
Gong 2021 · reproductive coding	nomination	gene-list membership	Source
Gong 2021 · reproductive noncoding	nomination	gene-list membership	Source
da Silva 2017 · tumor proteomics	nomination	gene-list membership	Source
Bai 2016	nomination	gene-list membership	Source
Boël et al., Immunity (1995)	nomination	gene-list membership	Source
Garg et al., Clinical Cancer Research (2007)	nomination	gene-list membership	Source
Sasaroli et al. (2011)	nomination	gene-list membership	Source
Hirbo et al. (2015)	nomination	gene-list membership	Source